Roche (SWX:ROP) Starts Breast Cancer Trial With Evexta Bio Using Two Drug Candidates
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
IDEAYA, Roche test IDE892/RG6505 in MTAP PDAC
IDEAYA entered into a clinical collaboration with Roche to evaluate IDE892, IDEAYA’s potential best-in-class Phase 1 MTA-cooperative PRMT5…
IDEAYA and Roche launch IDE892 combo study in PDAC
Item 8.01 Other Events. Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer On June 3, 2026, IDEAYA Biosciences, Inc.…